The researchers found that the annual rate of asthma attacks was:
> 0.93 for the 528 participants who got tezepelumab
> 2.10 for the 531 participants who got the placebo
This was a reduction in annual rate of 56.0% for the participants who got
tezepelumab compared to those who got the placebo.
The chart below shows these results.
Rate of asthma attacks over 1 year
(all participants who got study treatment) raey
2.5 1
revo
2.10
2.0
skcatta
1.5
0.93 amhtsa
1.0
0.5
fo
etaR
0.0
Tezepelumab Placebo
8 | Clinical Study Results